Prophylactic intra-aortic balloon pump in transfemoral transcatheter aortic valve implantation

DOI: 10.4244/EIJ-D-22-00798

Andrea Scotti
Andrea Scotti1,2, MD; Pier Pasquale Leone1, MD; Matteo Sturla1, MD; Jonathan Curio1, MD; Alexander M. Spring1, MD; Gaia Ressa1, MD; Sebastian Ludwig1,2, MD; Tadahisa Sugiura1, MD, PhD; Manaf Assafin1, MD; Juan F. Granada1,2, MD; Mei Chau1, MD; James Doolittle1, PA-C; Azeem Latib1, MD
1. Montefiore-Einstein Center for Heart and Vascular Care, Montefiore Medical Center/Albert Einstein College of Medicine, Bronx, NY, USA; 2. Cardiovascular Research Foundation, New York, NY, USA
The intra-aortic balloon pump (IABP) has been the most used mechanical circulatory support (MCS) device in the last 40 years. Its utility has been investigated in several clinical settings: cardiogenic shock, myocardial infarction, high-risk percutaneous coronary interventions, left ventricular unloading, and as a bridging strategy to high-risk cardiac surgery. However, no data on the feasibility of temporary MCS with an IABP during transfemoral transcatheter aortic valve implantation (TAVI) are available. From November 2021 to November 2022, eleven patients with severe aortic stenosis (AS) and a left ventricular ejection fraction (LVEF) <30% (low-flow, low-gradient: n=7) underwent elective transfemoral TAVI with prophylactic transfemoral IABP support. ...

Sign in to read and download the full article

Forgot your password?

No account yet?
Sign up for free!

Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from

Interventions for valvular diseaseTAVI
Read next article
Ultrasound-guided femoral access in patients with vascular closure devices: a prespecified analysis of the randomised UNIVERSAL trial

Latest news